Personalized contraception Adyn offers a unique, genetics and hormone profile driven approach to selecting birth control, presenting a targeted sales angle to healthcare providers, fertility clinics, and telehealth platforms focused on personalized medicine.

Small but growing With a lean team and early-stage revenue, there is a clear opportunity to partner with specialized distributors, contract research organizations, or digital health accelerators to scale adoption and early revenue growth.

Direct-to-consumer potential The Birth Control Test model enables patient self-selection and anonymous research participation, suggesting sales opportunities with consumer health platforms, digital pharmacies, and telemedicine services seeking risk-based enrollment features.

Tech stack leverage Existing technology footprint including AWS, data visualization, tracking pixels and ads suggests partnerships with digital marketing firms, analytics providers, and regulatory-compliant data partners to optimize outreach and measurement.

Market positioning Position adyn as a pioneer in closing the gender health gap, aligning with women’s health networks, academic partnerships, and insurer/biotech collaborations that fund personalized medicine and side-effect mitigation.